RecruitingNCT05911750

Prevalence and Clinical Implications of HPV Infection in Male IBD Patients

Prevalence and Clinical Implications of Human Papillomavirus Infection in the Male Population With Inflammatory Bowel Disease


Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Enrollment

384 participants

Start Date

Feb 12, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The study aims at describing the prevalence of Human Papillomavirus (HPV) infection in anal and oral samples of men with Inflammatory Bowel Disease (IBD) and detecting risk factors for the infection.


Eligibility

Sex: MALEMin Age: 18 YearsMax Age: 79 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Anal pap smear and oral swab for cytology and HPV testing for people with dysplasia anus, hpv infection, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 18 Years to 79 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTAnal pap smear and oral swab for cytology and HPV testing

Anal and oral swab sampling for HPV detection (polymerase chain reaction) and cytology


Locations(1)

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05911750


Related Trials